65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79722D0169
- Awardee
-
HLS Therapeutics Inc. UEI ME8TM7LFPS76
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 86% complete
- IDV ceiling
- $13,848,500.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
HLS Therapeutics Inc. was awarded a multiple-award Federal Supply Schedule contract on July 1, 2022, through the Pharmaceuticals and Drugs (FSS-61-IB) master schedule to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. The contract, which carries a ceiling value of $13,848,500.00 with no set-aside restrictions, establishes HLS Therapeutics as an authorized vendor for pharmaceutical and related medical products within the Federal Supply Schedule framework. The contract period extends through June 30, 2027, providing a four-year and eleven-month performance window for the delivery of these essential pharmaceutical supplies.
Under this Federal Supply Schedule contract, HLS Therapeutics will supply a range of pharmaceutical products classified under Commodities/Services Group 65 I B, which encompasses drugs, pharmaceuticals, and hematology-related products. The multiple-award structure allows VISN 12 to leverage HLS Therapeutics' pricing and availability alongside other qualified vendors on the same schedule, enabling flexibility in procurement decisions while ensuring competitive pricing through the established Federal Supply Schedule mechanism. The contract includes provisions for public pricing updates, ensuring transparency and compliance with GSA scheduling requirements throughout the contract period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79722D0169?
36F79722D0169 was awarded to HLS Therapeutics Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 1, 2022.
How much is contract 36F79722D0169 worth?
36F79722D0169's own ceiling is $13,848,500.
Who can order from contract 36F79722D0169?
36F79722D0169 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79722D0169 part of a contract vehicle?
Yes. 36F79722D0169 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79722D0169 competed?
The extent of competition for 36F79722D0169 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV